	An atypical presentation of lymphangitis carcinomatosis. BMJ Case Rep Xinyi KL, Ghanchi A, Chieng YW, Bhumenahalli M. PMID: 42613132 [PubMed - indexed for MEDLINE]
	A Phase I Study of Cyclical Hypofractionated Palliative Radiotherapy (Quad Shot) for Central Lung Tumors in Patients with Stage IV Non-Small Cell Lung Cancer (NSCLC): Results from the PROMISE 006 Trial Thoracic Quad Shot RT in Stage IV NSCLC. Int J Radiat Oncol Biol Phys Zhang YH, Iqbal A, Gelblum D, Ma J, Yorke E, Yang JT, Gillespie EF, Toumbacaris N, Zhang Z, Brooks P, Khalyat E, Shaverdian N, Brennan V, Guttmann DM, Imber BS, Iyengar P, Shin J, Simone CB 2nd, Wu AJ, Rimner A, Gomez D, Shepherd A. PMID: 42612834 [PubMed - as supplied by publisher]
	Forecasting Time-Dependent Radiation Induced Lymphocyte Depletion in a Clinical Trial on Early-Stage Lung Cancer. Int J Radiat Oncol Biol Phys Nguyen C, Chen J, Larner J, Colen J, Wijesooriya K. PMID: 42612832 [PubMed - as supplied by publisher]
	A phase 2 study of encorafenib in combination with binimetinib for Chinese participants with BRAF(V600E) mutated metastatic non-small cell lung cancer: Results from the OCEAN II study. Lung Cancer Zhou H, Zhou Q, Guo Q, Guo W, Chen G, Liu Z, Fan Y, Li Y, Chen YM, Bouras K, Frari LD, Guo A, Klauck I, Sansas B, Zhang L. PMID: 42612509 [PubMed - as supplied by publisher]
	Treatment-stratified associations of pathological complete response with survival in resected limited-stage small cell lung cancer: A multicenter retrospective study with exploratory spatial immune profiling. Lung Cancer Liu Z, Zhu Y, Bi W, Han Z, Xing X, Lu C, Liu Y, Yang Z, Xia Y, Li L. PMID: 42612508 [PubMed - as supplied by publisher]
	Expression of m6A Reader Protein YTHDC2 in Non-small Cell Lung Cancer in a Chinese Clinical Cohort. J Vis Exp Xiao H, Liang D, Liang W. PMID: 42611590 [PubMed - indexed for MEDLINE]
	"What really works for us?" exploring therapeutic strategies for non-small cell lung cancer: an umbrella review of systematic reviews and meta-analyses. Clin Transl Oncol Zhang X, Wang Y, Guan Y, Qu R. PMID: 42611130 [PubMed - as supplied by publisher]
	Behavioral speech therapy intervention can improve the postoperative pain and performance status of lung cancer patients undergoing thoracoscopic surgery. Support Care Cancer Zhang H, Jin Y, Song X, Liu C, Xi Z, Chen C, Tian Y, Hu Z. PMID: 42611082 [PubMed - indexed for MEDLINE]
	(68)Ga-NK224 PET/CT Reveals Intra- and Intertumoral Heterogeneity of PD-L1 in Non-Small Cell Lung Cancer. Radiology Zhao L, Zhou H, Yu L, Ruan D, Wu Z, Li Y, Dai Y, Li J, Sun L, Wu H, Mi Y, Chen H. PMID: 42610817 [PubMed - indexed for MEDLINE]
	Uneven Ground: Survival Differences Among Victorian Lung Cancer Patients by Location of Residence (2011-2023): A Retrospective Cohort Study. Med J Aust Samuel E, Paul E, Lloyd M, Tissera S, Underhill C, Parakh S, Parente P, Olesen I, Torres J, See K, Wright GM, Langton D, John T, Conron M, Bartlett J, Atkin N, Zeps N, Harden SV, Faisal W, Zalcberg JR, Stirling RG. PMID: 42610726 [PubMed - indexed for MEDLINE]
	Multidisciplinary Team Care for Early-Stage Lung Cancer in Low- and Middle-Income Countries and Emerging Economies: Current Position and Call for Action. Thorac Cancer Araujo LH, Orlandi FJ, Azam A, Viola L, Elkerm Y, Alatorre-Alexander J, Ba, Lyons GA, Li X, Lam Quoc T, Munshi A, Gonzalez F. PMID: 42610673 [PubMed - indexed for MEDLINE]
	A Single-Center Comparative Study of the c-MET Immunohistochemistry SP44 and LBP4 Assays in Chinese Non-Small Cell Lung Cancer (NSCLC) Cohort. Appl Immunohistochem Mol Morphol Wang Y, Liang Z, Song S, Liu B, Zhang H, Jiang L, Su Y, Wang W. PMID: 42610370 [PubMed - as supplied by publisher]
	Correction: 18F-FDG PET/CT for predicting major pathological response to neoadjuvant therapy in non-small cell lung cancer: a meta-analysis. Front Oncol Wu Y, Hu B, Liu D, Meng H. PMID: 42609794 [PubMed]
	Impact of lung cancer discovery mode on cancer outcomes: data from the KBP-2020-CPHG study. ERJ Open Res Grolleau E, Couraud S, Maurer C, Kraemer JP, Peloni JM, Raymond S, Le Floch H, Banciu N, Letierce A, Debieuvre D. PMID: 42609744 [PubMed]
	Dynamic Granulocyte Turnover Inferred From cfDNA Methylation Predicts Immunotherapy Benefit in Liver-Metastatic Small Cell Lung Cancer: A Prospective Biomarker Study. MedComm (2020) Tang N, Shang X, Sun Y, Zhang Y, Zhou H, Ye S, Tang X, Guo J, Zhang X, Gao X, Wang Z, Wang H. PMID: 42609700 [PubMed]
	Synergistic effects and clinical utilization of radioimmunotherapy for brain metastases from driver mutation-negative non-small cell lung cancer. Precis Radiat Oncol Yu S, Ni J, Chen H, Weng N, Yang X, Chu X, Chu L, Zhu Z. PMID: 42609674 [PubMed - as supplied by publisher]
	Toxicity of BEP chemotherapy in germ cell tumors: focus on immune-mediated bleomycin pulmonary toxicity in comparison with EP and VIP regimens. Front Immunol Olah P, Celec P, Vlkova B, Rejlekova K. PMID: 42609598 [PubMed - indexed for MEDLINE]
	Squamous transformation of EGFR-mutant lung adenocarcinoma after EGFR-TKI therapy: clonal continuity, tissue-based diagnosis, and therapeutic evidence gaps. Front Oncol Zhou L, Zhang P, Liu Q, Wang L. PMID: 42609500 [PubMed]
	Predictive value of nutritional biomarkers for immune checkpoint inhibitor efficacy in patients with non-small cell lung cancer. Front Nutr Zhang W, Liu X. PMID: 42609359 [PubMed]
	A dual-validated machine learning model for predicting 3-year mortality in atypical pulmonary carcinoid, a rare neuroendocrine tumor. Front Endocrinol (Lausanne) Chen Y, Luo X, Zhang H, Zhou J, Yu Y, Yang G, Chen J. PMID: 42609244 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 162376

Page 1 of 8119



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy